Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (141-150 of 236) with videos related to

Pageof 24
Sort By:
Journal of the American College of Cardiology|July 19, 2014
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosisSigrun Halvorsen, Felicita Andreotti, Jurriën M ten Berg, et al.
Frontiers in Cardiovascular Medicine|February 21, 2022
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in HumansEle Ferrannini, Maria Laura Manca, Giulia Ferrannini, et al.
Journal of Clinical Medicine|August 26, 2022
Antiplatelet Therapy during the First Year after Acute Coronary Syndrome in a Contemporary Italian Community of over 5 Million SubjectsSilvia Calabria, Felicita Andreotti, Giulia Ronconi, et al.
Circulation|September 13, 2003
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?Mario Gaudino, Felicita Andreotti, Roberto Zamparelli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2020
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trialsStefano Benenati, Mattia Galli, Vincenzo De Marzo, et al.
Atherosclerosis|December 14, 2011
Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trialsEliano Pio Navarese, Antonino Buffon, Felicita Andreotti, et al.
Journal of Thrombosis and Thrombolysis|April 17, 2004
4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective studyFrancesco Burzotta, Licia Iacoviello, Augusto Di Castelnuovo, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
International Journal of Cardiology|May 22, 2021
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE studyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
Haematologica|September 21, 2004
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndromeFrancesco Burzotta, Antonio Maria Leone, Katia Paciaroni, et al.
Pageof 24

Showing results (141-150 of 236) with videos related to

Sort By:
Pageof 24
Journal of the American College of Cardiology|July 19, 2014
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosisSigrun Halvorsen, Felicita Andreotti, Jurriën M ten Berg, et al.
Frontiers in Cardiovascular Medicine|February 21, 2022
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in HumansEle Ferrannini, Maria Laura Manca, Giulia Ferrannini, et al.
Journal of Clinical Medicine|August 26, 2022
Antiplatelet Therapy during the First Year after Acute Coronary Syndrome in a Contemporary Italian Community of over 5 Million SubjectsSilvia Calabria, Felicita Andreotti, Giulia Ronconi, et al.
Circulation|September 13, 2003
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?Mario Gaudino, Felicita Andreotti, Roberto Zamparelli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 17, 2020
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trialsStefano Benenati, Mattia Galli, Vincenzo De Marzo, et al.
Atherosclerosis|December 14, 2011
Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trialsEliano Pio Navarese, Antonino Buffon, Felicita Andreotti, et al.
Journal of Thrombosis and Thrombolysis|April 17, 2004
4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective studyFrancesco Burzotta, Licia Iacoviello, Augusto Di Castelnuovo, et al.
Thrombosis and Haemostasis|November 4, 2011
Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on ThrombosisGregory Y H Lip, Felicita Andreotti, Laurent Fauchier, et al.
International Journal of Cardiology|May 22, 2021
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE studyMartino Deidda, Antonio Noto, Christian Cadeddu Dessalvi, et al.
Haematologica|September 21, 2004
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndromeFrancesco Burzotta, Antonio Maria Leone, Katia Paciaroni, et al.
Pageof 24